CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1569.80-2.15 (-0.14 %)
PREV CLOSE ( ) 1571.95
OPEN PRICE ( ) 1571.50
BID PRICE (QTY) 1570.05 (3)
OFFER PRICE (QTY) 1572.70 (15)
VOLUME 2760
TODAY'S LOW / HIGH ( )1563.05 1595.00
52 WK LOW / HIGH ( )900 1711.95
NSE1570.45-1.35 (-0.09 %)
PREV CLOSE( ) 1571.80
OPEN PRICE ( ) 1574.75
BID PRICE (QTY) 1570.20 (6)
OFFER PRICE (QTY) 1572.10 (8)
VOLUME 36901
TODAY'S LOW / HIGH( ) 1562.80 1595.40
52 WK LOW / HIGH ( )900.05 1725

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.